Journal of Cataract & Refractive Surgery
Volume 36, Issue 2 , Pages 203-207 , February 2010

Effectiveness of intracameral cefuroxime in preventing endophthalmitis after cataract surgery: Ten-year comparative study

Received 4 July 2009 ,Revised 2 August 2009 ,Accepted 4 August 2009.

References 

  1. Kamalarajah S, Silvestri G, Sharma N, Khan A, Foot B, Ling R, et al. Surveillance of endophthalmitis following cataract surgery in the UK. Eye. 2004;18:580–587Available at: http://www.nature.com/eye/journal/v18/n6/pdf/6700645a.pdfAccessed October 2, 2009
  2. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study; a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113:1479–1496
  3. Patwardhan A, Rao GP, Saha K, Craig EA. Incidence and outcomes evaluation of endophthalmitis management after phacoemulsification and 3-piece silicone intraocular lens implantation over 6 years in a single eye unit. J Cataract Refract Surg. 2006;32:1018–1021
  4. Lundström M, Wejde G, Stenevi U, Thorburn W, Montan P. Endophthalmitis after cataract surgery; a nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology. 2007;114:866–870
  5. Taban M, Behrens A, Newcomb RL, Nobe MY, Saedi G, Sweet PM, et al. Acute endophthalmitis following cataract surgery; a systematic review of the literature. Arch Ophthalmol. 2005;123:613–620
  6. Javitt JC, Kendix M, Tielsch JM, Steinwachs DM, Schein OD, Kolb MM, et al. Geographic variation in utilization of cataract surgery. Med Care. 1995;33:90–105
  7. Foster A. Cataract and “Vision 2020—the right to sight” initiative [editorial]. Br J Ophthalmol. 2001;85:635–637Available at: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1724020&blobtype=pdfAccessed October 2, 2009
  8. Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery; an evidence-based update. Ophthalmology. 2002;109:13–24
  9. Wu P-C, Li M, Chang S-J, Teng M-C, Yow S-G, Shin S-J, et al. Risk of endophthalmitis after cataract surgery using different protocols for povidone–iodine preoperative disinfection. J Ocul Pharmacol Ther. 2006;22:54–61
  10. Barry P, Seal DV, Gettinby G, Lees F, Peterson M, Revie CW. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; preliminary report of principal results from a European multicenter study; the ESCRS Endophthalmitis Study Group. J Cataract Refract Surg. 2006;32:407–410
  11. ESCRS Endophthalmitis Study Group. Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33:978–988
  12. O'Brien TP, Arshinoff SA, Mah FS. Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin. J Cataract Refract Surg. 2007;33:1790–1800
  13. Lemley CA, Han DP. Endophthalmitis; a review of current evaluation and management. Retina. 2007;27:662–680
  14. Gordon-Bennett P, Karas A, Flanagan D, Stephenson C, Hingorani M. A survey of measures used for the prevention of postoperative endophthalmitis after cataract surgery in the United Kingdom. Eye. 2008;22:620–627
  15. Gore DM, Angunawela RI, Little BC. United Kingdom survey of antibiotic prophylaxis practice after publication of the ESCRS Endophthalmitis Study. J Cataract Refract Surg. 2009;35:770–773
  16. Montan PG, Wejde G, Koranyi G, Rylander M. Prophylactic intracameral cefuroxime; efficacy in preventing endophthalmitis after cataract surgery. J Cataract Refract Surg. 2002;28:977–981
  17. Montan PG, Wejde G, Setterquist H, Rylander M, Zetterström C. Prophylactic intracameral cefuroxime; evaluation of safety and kinetics in cataract surgery. J Cataract Refract Surg. 2002;28:982–987
  18. Díez MR, de la Rosa G, Pascual R, Girón C, Arteta M. Profilaxis de la endoftalmitis postquirúrgia con cefuroxima intracamerular: experiencia de cincos años. [Prophylaxis of postoperative endophthalmitis with intracameral cefuroxime: a five years' experience]. Arch Soc Esp Oftalmol. 2009;84:85–90
  19. Yu-Wai-Man P, Morgan SJ, Hidreth AJ, Steel DH, Allen D. Efficacy of intracameral and subconjunctival cefuroxime in preventing endophthalmitis after cataract surgery. J Cataract Refract Surg. 2008;34:447–451
  20. Lane SS, Osher RH, Masket S, Belani S. Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery. J Cataract Refract Surg. 2008;34:1451–1459
  21. Arbisser LB. Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery. J Cataract Refract Surg. 2008;34:1114–1120
  22. Scoper SV. Review of third- and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy. Adv Ther. 2008;25:979–994
  23. Jensen MK, Fiscella RG, Moshirfar M, Mooney B. Third- and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years. J Cataract Refract Surg. 2008;34:1460–14670

PII: S0886-3350(09)00991-2

doi: 10.1016/j.jcrs.2009.08.023

Journal of Cataract & Refractive Surgery
Volume 36, Issue 2 , Pages 203-207 , February 2010

Article Tools